Notes - Segment Information

Astellas Pharma Inc. - Filing #7258550

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
Notes - Segment information
Segment information
Revenue
Revenue
1,912,323,000,000 JPY
1,603,672,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-259,000,000 JPY
-3,165,000,000 JPY
Profit (loss) before tax
31,237,000,000 JPY
24,969,000,000 JPY
Assets
3,339,544,000,000 JPY
3,569,603,000,000 JPY
Investments accounted for using equity method
18,989,000,000 JPY
15,684,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.